Very few sexually active gay and bisexual men use prophylactic drug to prevent HIV transmission, study finds

logo2.png

BY JENNIFER MCNULTY

UNIVERSITY OF CALIFORNIA, SANTA CRUZ

SEPTEMBER 12, 2018

Only 4 percent of sexually active gay and bisexual men in the United States use Truvada, a highly effective medication used to prevent the transmission of HIV, according to the results of a first-of-its-kind study.

Led by Psychology Professor Phillip Hammack, the study, "HIV Testing and Pre-Exposure Prophylaxis (PrEP) Use, Familiarity, and Attitudes among Gay and Bisexual Men in the United States: A National Probability Sample of Three Birth Cohorts," was published Sept. 7 in the journal PLOS ONE.

For the full article click here